Home / Business and Economy / Sun Pharma Invests ₹3,000 Crore in New MP Plant
Sun Pharma Invests ₹3,000 Crore in New MP Plant
3 Dec
Summary
- Sun Pharma subsidiary plans a new manufacturing plant.
- The investment earmarked for the new facility is Rs 3,000 crore.
- The plant will be established in Madhya Pradesh.
Sun Pharmaceutical Industries, through its wholly-owned subsidiary Sun Pharma Laboratories Ltd, has announced plans for a substantial investment in India. The company's board has approved a proposal to establish a greenfield formulations manufacturing facility in Madhya Pradesh, signaling a major commitment to expanding its production capabilities.
This new venture represents a significant financial outlay, with an estimated investment of Rs 3,000 crore dedicated to the construction and operationalization of the plant. The strategic location in Madhya Pradesh is expected to bolster Sun Pharma's manufacturing footprint and contribute to its growth objectives within the pharmaceutical sector.
The announcement coincided with a positive market performance for Sun Pharma, whose shares closed at Rs 1,805.70 on the BSE, marking a 0.43% increase. This investment highlights the company's confidence in the Indian market and its ongoing strategy to enhance its domestic manufacturing infrastructure.
